|
1
|
Rogalski TM, Mullen GP, Gilbert MM,
Williams BD and Moerman DG: The UNC-112 gene in Caenorhabditis
elegans encodes a novel component of cell-matrix adhesion
structures required for integrin localization in the muscle cell
membrane. J Cell Biol. 150:253–264. 2000.PubMed/NCBI
|
|
2
|
Wegener KL, Partridge AW, Han J, et al:
Structural basis of integrin activation by talin. Cell.
128:171–182. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ussar S, Wang HV, Linder S, Fässler R and
Moser M: The Kindlins: subcellular localization and expression
during murine development. Exp Cell Res. 312:42–51. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shi X, Ma YQ, Tu Y, et al: The
MIG-2/integrin interaction strengthens cell-matrix adhesion and
modulates cell motility. J Biol Chem. 282:20455–20466. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim M, Carman CV and Springer TA:
Bidirectional transmembrane signaling by cytoplasmic domain
separation in integrins. Science. 301:1720–1725. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Montanez E, Ussar S, Schifferer M, Bösl M,
Zent R, Moser M and Fässler R: Kindlin-2 controls bidirectional
signaling of integrins. Genes Dev. 22:1325–1330. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
An Z, Dobra K, Lock JG, Strömblad S,
Hjerpe A and Zhang H: Kindlin-2 is expressed in malignant
mesothelioma and is required for tumor cell adhesion and migration.
Int J Cancer. 127:1999–2008. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gong X, An Z, Wang Y, et al: Kindlin-2
controls sensitivity of prostate cancer cells to cisplatin-induced
cell death. Cancer Lett. 299:54–62. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kato K, Shiozawa T, Mitsushita J, et al:
Expression of the mitogen-inducible gene-2 (mig-2) is elevated in
human uterine leiomyomas but not in leiomyosarcomas. Hum Pathol.
35:55–60. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sgambato A and Cittadini A: Inflammation
and cancer: a multifaceted link. Eur Rev Med Pharmacol Sci.
14:263–268. 2010.
|
|
11
|
Hagemann T, Balkwill F and Lawrence T:
Inflammation and cancer: a double-edged sword. Cancer Cell.
12:300–301. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mukhtar RA, Nseyo O, Campbell MJ and
Esserman LJ: Tumor-associated macrophages in breast cancer as
potential biomarkers for new treatments and diagnostics. Expert Rev
Mol Diagn. 11:91–100. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang BC, Gao J, Wang J, Rao ZG, Wang BC
and Gao JF: Tumor-associated macrophages infiltration is associated
with peritumoral lymphangiogenesis and poor prognosis in lung
adenocarcinoma. Med Oncol. 28:1447–1452. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ohno S, Ohno Y, Suzuki N, et al:
Correlation of histological localization of tumor-associated
macrophages with clinicopathological features in endometrial
cancer. Anticancer Res. 24:3335–3342. 2004.PubMed/NCBI
|
|
15
|
Hanada T, Nakagawa M, Emoto A, Nomura T,
Nasu N and Nomura Y: Prognostic value of tumor-associated
macrophage count in human bladder cancer. Int J Urol. 7:263–269.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Leek RD, Lewis CE, Whitehouse R, Greenall
M, Clarke J and Harris AL: Association of macrophage infiltration
with angiogenesis and prognosis in invasive breast carcinoma.
Cancer Res. 56:4625–4629. 1996.PubMed/NCBI
|
|
17
|
Fujimoto H, Sangai T, Ishii G, et al:
Stromal MCP-1 in mammary tumors induces tumor-associated macrophage
infiltration and contributes to tumor progression. Int J Cancer.
125:1276–1284. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Koga F, Kageyama Y, Kawakami S, et al:
Prognostic significance of endothelial Per-Arnt-sim domain protein
1/hypoxia-inducible factor-2alpha expression in a subset of tumor
associated macrophages in invasive bladder cancer. J Urol.
171:1080–1084. 2004. View Article : Google Scholar
|
|
19
|
Rajkumar T, Vijayalakshmi N, Gopal G,
Sabitha K, Shirley S, Raja UM and Ramakrishnan SA: Identification
and validation of genes involved in gastric tumorigenesis. Cancer
Cell Int. 10:452010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jackson CB, Judd LM, Menheniott TR, et al:
Augmented gp130-mediated cytokine signalling accompanies human
gastric cancer progression. J Pathol. 213:140–151. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Won HH, Kim JW, Kim MJ, Kim S, Park JH and
Lee KA: Interleukin 10 polymorphisms differentially influence the
risk of gastric cancer in East Asians and Caucasians. Cytokine.
51:73–77. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mantovani A, Sozzani S, Locati M, Allavena
P and Sica A: Macrophage polarization: tumor-associated macrophages
as a paradigm for polarized M2 mononuclear phagocytes. Trends
Immunol. 23:549–555. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lewis C and Murdoch C: Macrophage
responses to hypoxia: implications for tumor progression and
anti-cancer therapies. Am J Pathol. 167:627–635. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Culig Z: Cytokine disbalance in common
human cancers. Biochim Biophys Acta. 1813:308–314. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Savage SA, Abnet CC, Mark SD, et al:
Variants of the IL8 and IL8RB genes and risk for gastric cardia
adenocarcinoma and esophageal squamous cell carcinoma. Cancer
Epidemiol Biomarkers Prev. 13:2251–2257. 2004.PubMed/NCBI
|
|
26
|
Waugh D and Wilson C: The interleukin-8
pathway in cancer. Clin Cancer Res. 14:6735–6741. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Thong-Ngam D, Tangkijvanich P, Lerknimitr
R, Mahachai V, Theamboonelrs A and Poovorawan Y: Diagnostic role of
serum interleukin-18 in gastric cancer patients. World J
Gastroenterol. 12:4473–4477. 2006.PubMed/NCBI
|
|
28
|
Szaflarska A, Szczepanik A, Siedlar M,
Czupryna A, Sierzega M, Popiela T and Zembala M: Preoperative
plasma level of IL-10 but not of proinflammatory cytokines is an
independent prognostic factor in patients with gastric cancer.
Anticancer Res. 29:5005–5012. 2009.PubMed/NCBI
|
|
29
|
Paul SR, Bennett F, Calvetti JA, et al:
Molecular cloning of a cDNA encoding interleukin 11, a stromal
cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl
Acad Sci USA. 87:7512–7516. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Du X and Williams DA: Interleukin-11:
review of molecular, cell biology, and clinical use. Blood.
89:3897–3908. 1997.PubMed/NCBI
|
|
31
|
Nakayama T, Yoshizaki A, Izumida S, et al:
Expression of interleukin-11 (IL-11) and IL-11 receptor alpha in
human gastric carcinoma and IL-11 upregulates the invasive activity
of human gastric carcinoma cells. Int J Oncol. 30:825–833.
2007.PubMed/NCBI
|
|
32
|
Okano F and Yamada K: Canine
interleukin-18 induces apoptosis and enhances Fas ligand mRNA
expression in a canine carcinoma cell line. Anticancer Res.
20:3411–3415. 2000.PubMed/NCBI
|
|
33
|
Coughlin CM, Salhany KE, Wysocka M, et al:
Interleukin-12 and interleukin-18 synergistically induce murine
tumor regression which involves inhibition of angiogenesis. J Clin
Invest. 101:1441–1452. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cho D, Song H, Kim YM, et al: Endogenous
interleukin-18 modulates immune escape of murine melanoma cells by
regulating the expression of Fas ligand and reactive oxygen
intermediates. Cancer Res. 60:2703–2709. 2000.PubMed/NCBI
|
|
35
|
Lissoni P, Brivio F, Rovelli F, et al:
Serum concentrations of interleukin-18 in early and advanced cancer
patients: enhancedsecretion in metastatic disease. J Biol Regul
Homeost Agents. 14:275–277. 2000.PubMed/NCBI
|
